As of April 16, 2025, Harrow Health (HROW) has a market cap of $0.85 billion USD. According to our data, Harrow Health is ranked No.5257 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.85 B |
-29.01%
|
Dec 31, 2024 | $1.19 B |
199.55%
|
Dec 29, 2023 | $0.40 B |
-24.12%
|
Dec 30, 2022 | $0.53 B |
70.83%
|
Dec 31, 2021 | $0.31 B |
25.95%
|
Dec 31, 2020 | $0.24 B |
-11.83%
|
Dec 31, 2019 | $0.28 B |
36.73%
|
Dec 31, 2018 | $0.20 B |
234.71%
|
Dec 29, 2017 | $60.54 M |
-32.00%
|
Dec 30, 2016 | $89.04 M |
-63.92%
|
Dec 31, 2015 | $0.25 B |
-7.60%
|
Dec 31, 2014 | $0.27 B |
123.21%
|
Dec 31, 2013 | $0.12 B |
-65.54%
|
Dec 31, 2012 | $0.35 B |
103.12%
|
Dec 30, 2011 | $0.17 B |
-84.81%
|
Dec 31, 2010 | $1.13 B |
-47.33%
|
Dec 31, 2009 | $2.14 B |
50.00%
|
Dec 31, 2008 | $1.42 B |
-63.64%
|
Dec 31, 2007 | $3.92 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Bausch Health
BHC
|
$1.67 B |
-0.000 M
|
![]() Canada
|
![]() Amneal Pharmaceuticals
AMRX
|
$3.34 B |
1.091 B
|
![]() USA
|
![]() Perrigo
PRGO
|
$3.42 B |
-0.000 M
|
![]() Ireland
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
![]() Israel
|
![]() Viatris
VTRS
|
$8.93 B |
-0.000 M
|
![]() USA
|
![]() Catalent
CTLT
|
$11.52 B |
0.000 M
|
![]() USA
|
![]() Jazz Pharmaceuticals
JAZZ
|
$6.25 B |
0.000 M
|
![]() Ireland
|
![]() Alkermes
ALKS
|
$4.61 B |
-0.000 M
|
![]() Ireland
|
![]() Pacira Biosciences
PCRX
|
$1.15 B |
-0.000 M
|
![]() USA
|
![]() Collegium Pharmaceutical
COLL
|
$0.87 B |
0.000 M
|
![]() USA
|
![]() Assertio Therapeutics
ASRT
|
$60.28 M |
-0.000 M
|
![]() USA
|
![]() Supernus Pharmaceuticals
SUPN
|
$1.76 B |
-0.000 M
|
![]() USA
|
Market Cap | = | HROW Stock Price | * | HROW Shares Outstanding |
= | $23.79 | * | 35.65 M | |
= | $0.85 B |